| Cholangiocarcinoma 2020: the next horizon in mechanisms and management JM Banales, JJG Marin, A Lamarca, PM Rodrigues, SA Khan, LR Roberts, ... Nature reviews Gastroenterology & hepatology 17 (9), 557-588, 2020 | 1997 | 2020 |
| Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties C Coulouarn, VM Factor, JB Andersen, ME Durkin, SS Thorgeirsson Oncogene 28 (40), 3526-3536, 2009 | 933 | 2009 |
| Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype P Kaposi-Novak, JS Lee, L Gòmez-Quiroz, C Coulouarn, VM Factor, ... The Journal of clinical investigation 116 (6), 1582-1595, 2006 | 471 | 2006 |
| Transforming growth factor‐β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer C Coulouarn, VM Factor, SS Thorgeirsson Hepatology 47 (6), 2059-2067, 2008 | 388 | 2008 |
| Hepatocyte–stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma C Coulouarn, A Corlu, D Glaise, I Guénon, SS Thorgeirsson, B Clément Cancer research 72 (10), 2533-2542, 2012 | 235 | 2012 |
| Hepatocyte growth factor, transforming growth factor α, and their receptors as combined markers of prognosis in hepatocellular carcinoma M Daveau, M Scotte, A François, C Coulouarn, G Ros, Y Tallet, M Hiron, ... Molecular Carcinogenesis: Published in cooperation with the University of …, 2003 | 202 | 2003 |
| Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages C Raggi, M Correnti, A Sica, JB Andersen, V Cardinale, D Alvaro, ... Journal of hepatology 66 (1), 102-115, 2017 | 166 | 2017 |
| Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma C Coulouarn, B Clément Journal of hepatology 60 (6), 1306-1309, 2014 | 158 | 2014 |
| Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma L Sulpice, M Rayar, M Desille, B Turlin, A Fautrel, E Boucher, ... Hepatology 58 (6), 1992-2000, 2013 | 147 | 2013 |
| Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways C Coulouarn, C Cavard, L Rubbia-Brandt, A Audebourg, F Dumont, ... Carcinogenesis 33 (9), 1791-1796, 2012 | 123 | 2012 |
| Transforming growth factor‐β and Axl induce CXCL5 and neutrophil recruitment in hepatocellular carcinoma C Haider, J Hnat, R Wagner, H Huber, G Timelthaler, M Grubinger, ... Hepatology 69 (1), 222-236, 2019 | 120 | 2019 |
| Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis LE Gomez-Quiroz, VM Factor, P Kaposi-Novak, C Coulouarn, EA Conner, ... Journal of Biological Chemistry 283 (21), 14581-14589, 2008 | 118 | 2008 |
| AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation S Abitbol, R Dahmani, C Coulouarn, B Ragazzon, B Mlecnik, N Senni, ... Journal of hepatology 68 (6), 1203-1213, 2018 | 103 | 2018 |
| Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin E Lavergne, I Hendaoui, C Coulouarn, C Ribault, J Leseur, PA Eliat, ... Oncogene 30 (4), 423-433, 2011 | 102 | 2011 |
| The IGF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma J Vaquero, C Lobe, S Tahraoui, A Clapéron, M Mergey, F Merabtene, ... Clinical Cancer Research 24 (17), 4282-4296, 2018 | 98 | 2018 |
| Inflammatory cytokines promote the retrodifferentiation of tumor‐derived hepatocyte‐like cells to progenitor cells H Dubois‐Pot‐Schneider, K Fekir, C Coulouarn, D Glaise, C Aninat, ... Hepatology 60 (6), 2077-2090, 2014 | 95 | 2014 |
| Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines J Dzieran, J Fabian, T Feng, C Coulouarn, I Ilkavets, A Kyselova, ... PloS one 8 (8), e72252, 2013 | 92 | 2013 |
| TGF-β1 and TGF-β2 abundance in liver diseases of mice and men A Dropmann, T Dediulia, K Breitkopf-Heinlein, H Korhonen, M Janicot, ... Oncotarget 7 (15), 19499, 2016 | 82 | 2016 |
| Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance L Fouassier, M Marzioni, MB Afonso, S Dooley, K Gaston, G Giannelli, ... Liver International 39, 43-62, 2019 | 76 | 2019 |
| Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating … L Grumolato, AG Elkahloun, H Ghzili, D Alexandre, C Coulouarn, L Yon, ... Endocrinology 144 (6), 2368-2379, 2003 | 74 | 2003 |
